These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7692559)

  • 21. Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box.
    Zernig G; Troger J; Saria A
    Neurosci Lett; 1993 Mar; 151(1):64-6. PubMed ID: 7682312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat.
    Ren K; Iadarola MJ; Dubner R
    Br J Pharmacol; 1996 Jan; 117(1):196-202. PubMed ID: 8825363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous injection of endokinin C/D attenuates carrageenan-induced inflammation.
    Naono-Nakayama R; Sunakawa N; Ikeda T; Matsushima O; Nishimori T
    Peptides; 2010 Sep; 31(9):1767-71. PubMed ID: 20638946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cannabidiolic acid and ∆
    Rock EM; Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2018 Nov; 235(11):3259-3271. PubMed ID: 30225659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (+/-)-CP-96,345, an NK1 receptor antagonist, has local anaesthetic-like effects in a mammalian sciatic nerve preparation.
    Karlsson U; Näsström J; Berge OG
    Regul Pept; 1994 Jun; 52(1):39-46. PubMed ID: 7972930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of substance P and related peptides by RP 67580 and CP-96,345, at tachykinin NK1 receptor sites, in the rat urinary bladder.
    Montier F; Carruette A; Moussaoui S; Boccio D; Garret C
    Eur J Pharmacol; 1994 Jan; 251(1):9-14. PubMed ID: 7511108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of potent antinociceptive activity by substance P antagonist CP-96,345 in the rat spinal cord.
    Garces YI; Rabito SF; Minshall RD; Sagen J
    Life Sci; 1993; 52(4):353-60. PubMed ID: 7678436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
    Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
    Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of tachykinin antagonists on inflammation].
    Lundberg JM
    Lakartidningen; 1995 Feb; 92(6):533-5. PubMed ID: 7853938
    [No Abstract]   [Full Text] [Related]  

  • 30. Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models.
    Teodoro FC; Tronco Júnior MF; Zampronio AR; Martini AC; Rae GA; Chichorro JG
    Neuropeptides; 2013 Jun; 47(3):199-206. PubMed ID: 23177733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse.
    Velázquez RA; Kitto KF; Larson AA
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and neurokinin antagonist activity of 2-benzylidene- and 2-benzyl-3-benzylamino quinuclidines.
    Caliendo G; Greco G; Perissutti E; Santagada V; Silipo C; Vittoria A; Turbanti L; Renzetti AR; Benedetti E; Pedone C
    Farmaco; 1993 Oct; 48(10):1359-78. PubMed ID: 8117379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertension.
    Kohlmann O; Ginoza M; Cezaretti ML; Zanella MT; Ribeiro AB; Tavares A; Ramos OL; Leeman SE; Gavras I; Gavras H
    Hypertension; 1995 Dec; 26(6 Pt 2):1186-9. PubMed ID: 7498993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of the carotid body sensory response to hypoxia by the substance P receptor antagonist CP-96,345.
    Prabhakar NR; Cao H; Lowe JA; Snider RM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10041-5. PubMed ID: 8234254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of nociceptive responses of cat spinal dorsal horn neurons in vivo by the NK-1 receptor antagonists CP-96,345 and CP-99,994, but not by CP-96,344.
    Radhakrishnan V; Henry JL
    Neuroscience; 1995 Feb; 64(4):943-58. PubMed ID: 7538641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation.
    Comelli F; Giagnoni G; Bettoni I; Colleoni M; Costa B
    Br J Pharmacol; 2007 Nov; 152(5):787-94. PubMed ID: 17700715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of effects of morphine and CP-96,345, a substance P antagonist, administered intrathecally on the somatosympathetic reflex discharges in anesthetized rats.
    Adachi T; Sato A; Sato Y
    Regul Pept; 1993 Jul; 46(1-2):263-5. PubMed ID: 7692511
    [No Abstract]   [Full Text] [Related]  

  • 38. Tachykinins, via NK1 receptor activation, play a relevant role in plasma protein extravasation evoked by allergen challenge in the airways of sensitized guinea-pigs.
    Bertrand C; Geppetti P; Baker J; Yamawaki I; Nadel JA
    Regul Pept; 1993 Jul; 46(1-2):214-6. PubMed ID: 7692494
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal co-administration of NMDA antagonist and NK-1 antagonist reduces MAC of isoflurane in rats.
    Ishizaki K; Sasaki M; Karasawa S; Obata H; Nara T; Goto F
    Acta Anaesthesiol Scand; 1999 Aug; 43(7):753-9. PubMed ID: 10456816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.